The First Federal NEC Formula Case Is In Front of a Jury Right Now
On 19 August 2026 a jury in Chicago began hearing Inman v. Mead Johnson, the first case from the federal NEC baby formula litigation to reach trial. This is not a settlement, there is no claim form, and nobody can file for a payout. What is happening is a test case whose outcome will shape what roughly 825 pending families are offered. This page explains what is actually being decided, and corrects the two things coverage of this case gets wrong most often.
Editorially Reviewed — Content reviewed for accuracy using published legal research, government data, and verified court records. See our methodology
Reviewed by Leonard Goldberg, Editor · Last updated
What These Cases Allege
Necrotising enterocolitis is a condition in which intestinal tissue in a premature infant becomes inflamed and can die. It is a recognised risk of prematurity itself. The lawsuits do not claim that cow's-milk-based formula is the only cause of NEC. They claim something narrower and legally specific: that Abbott and Mead Johnson knew of research associating their preterm formula products with elevated NEC risk and did not warn parents or, in some claims, clinicians. The products at the centre of the litigation are Abbott's Similac line for preterm infants and Mead Johnson's Enfamil Premature. Both companies deny the allegations and continue to defend the cases; the causation question is genuinely contested and is precisely what juries are being asked to weigh.
Case Details
In re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation, MDL No. 3026, United States District Court for the Northern District of Illinois, Chief Judge Rebecca R. Pallmeyer presiding. The case now at trial is Inman et al. v. Mead Johnson & Co. LLC, No. 1:22-cv-03737. Related cases have also been tried in Illinois and Missouri state courts.
Where the Litigation Stands Today
Active litigation, no settlement programme. Jury selection in Inman v. Mead Johnson began on 19 August 2026 before Chief Judge Pallmeyer. It is the first of four initial bellwether cases from MDL 3026 to reach a jury, and the first federal NEC trial of any kind — every previous verdict in this litigation came out of state court. Alexis Inman alleges that Enfamil Premature contributed to her son Daniel Windley developing NEC; he died in 2020 of NEC-related shock.
The federal docket held roughly 825 pending cases at the Judicial Panel's 3 August 2026 census, with litigation trackers reporting about 810 filed as of mid-July. The count moves as cases are filed and consolidated.
Abbott announced a partial settlement in August 2026 — and it is genuinely partial. The reported figure is approximately $670 million covering around 2,000 claims brought by three plaintiffs' firms whose clients were already represented. There is no claims administrator, no claim form, no published deadline and no route for an unrepresented family to enter it. Abbott's own language describes it as a step toward substantially resolving the litigation, not a resolution of it. Mead Johnson and its parent Reckitt have no settlement at all, which is why their first federal bellwether is being tried rather than resolved.
Who These Cases Involve
The families bringing these claims share a narrow fact pattern. Broadly they involve an infant who was born prematurely, was fed a cow's-milk-based preterm formula or fortifier in a neonatal intensive care unit, and was subsequently diagnosed with necrotising enterocolitis — in many cases requiring surgery, and in the most serious cases resulting in death or lasting intestinal injury.
Three things matter more than they might appear to:
- Medical records are the case. NICU feeding records showing which product was given, and the NEC diagnosis itself, are what distinguish a claim from a suspicion. Hospitals do not keep these indefinitely and families often do not hold copies.
- Time limits vary by state and are not generous. Deadlines for injury claims differ from state to state, and rules for claims involving a child's injury or a death follow their own separate tracks. This is the most common way a viable claim stops being one.
- Donor human milk cases are not these cases. If a NICU used pasteurised donor milk rather than cow's-milk formula, the factual basis of this litigation does not apply.
There is nothing to file, apply for or register at present. What exists is litigation, and entering it means bringing a claim — which is a decision to take with a lawyer, not a form to submit.
What the Verdicts Actually Held
Four state-court verdicts are usually cited in coverage of this litigation, and they point in different directions. Read together they are the most honest available guide to what juries have made of the evidence.
March 2024 — $60 million against Mead Johnson in Illinois state court, for the mother of an infant who died. That verdict was overturned on appeal on 16 June 2026, on grounds including errors in jury instructions and the admission of evidence. It is routinely quoted as a live number; it is not one.
July 2024 — $495 million against Abbott in St. Louis, comprising $95 million in compensatory and $400 million in punitive damages. A Missouri appellate court upheld it on 8 May 2026, finding no reversible error. Abbott subsequently reached a confidential settlement with that family. This is the largest verdict in the litigation and the one that survived review.
April 2026 — $70 million against Abbott in Chicago: $53 million compensatory plus $17 million punitive. Both figures circulate separately in press coverage as though they were two different cases. They are one case.
And one jury found for the companies. A Missouri jury cleared both defendants; the trial judge vacated that verdict and ordered a retrial. Any account of this litigation that lists only the plaintiff wins is not describing it accurately.
What none of this gives you is a personal figure. Verdicts are not settlement values, two of these four have been disturbed on review, and individual outcomes turn on the severity of injury, the strength of the feeding records and the state whose law applies. Anyone quoting you an expected payout for a NEC claim today is quoting a marketing number.
How the Litigation Developed
- 1
April 2022 — the MDL is created
The Judicial Panel on Multidistrict Litigation consolidates federal preterm infant nutrition cases as MDL 3026 in the Northern District of Illinois before Chief Judge Rebecca Pallmeyer, centralising pretrial proceedings against Abbott and Mead Johnson.
- 2
March 2024 — $60 million against Mead Johnson
An Illinois state jury awards $60 million to the mother of an infant who died of NEC after being fed Enfamil. The verdict draws national attention and is widely cited for the next two years.
- 3
July 2024 — $495 million against Abbott
A St. Louis jury awards $95 million in compensatory and $400 million in punitive damages against Abbott, finding the company failed to warn of NEC risk. It remains the largest verdict in the litigation.
- 4
April 2026 — $70 million against Abbott
A Chicago jury awards $53 million compensatory and $17 million punitive against Abbott. The two components are frequently reported as separate verdicts; they are one.
- 5
8 May and 16 June 2026 — the appeals split
A Missouri appellate court upholds the $495 million Abbott verdict, finding no reversible error. Five weeks later the $60 million Mead Johnson verdict is overturned over jury-instruction and evidentiary errors. One survives review, one does not.
- 6
August 2026 — Abbott settles part of its exposure
Abbott agrees to pay approximately $670 million to resolve around 2,000 claims already brought by three plaintiffs' firms. No claims administrator is appointed and no public claim process opens, because the settlement covers represented clients rather than a class.
- 7
19 August 2026 — the first federal trial begins
Inman v. Mead Johnson goes to a jury in Chicago: the first bellwether from MDL 3026 to be tried and the first federal NEC verdict in prospect. Mead Johnson, unlike Abbott, has settled nothing.
What to Be Careful About
Litigation with large verdicts in the headlines and no official claim process is fertile ground for people offering one. These are the patterns that follow this particular case.
"File your NEC claim before the deadline"
There is no NEC claim form and no settlement deadline, because there is no global settlement — Abbott's August 2026 agreement covers roughly 2,000 already-represented claimants and appointed no administrator, and Mead Johnson has settled nothing. Any site presenting a countdown clock, a claim portal or a filing fee for a NEC settlement is describing something that does not exist. Real time limits in this litigation are state law deadlines for bringing a lawsuit, which vary by state and are a question for a lawyer, not a form.
Quoted payout figures drawn from the verdicts
The $495 million and $60 million numbers appear constantly in advertising as though they indicated what a family might receive. They do not. One was a single Missouri verdict including $400 million in punitive damages, and the other was overturned on appeal in June 2026. Verdicts are not settlement values, punitive awards are not typical, and appellate courts have already disturbed half the verdicts in this litigation. A firm quoting an expected figure before reading the NICU records is selling, not assessing.
Requests for medical records through unexpected channels
Assembling NICU feeding records and the NEC diagnosis is a genuine and necessary step, which is what makes an unsolicited call or text asking for them effective. Infant medical records are highly sensitive. Verify independently who is asking, confirm the firm exists and is licensed in the relevant state, and send records through a channel you initiated. A legitimate firm will wait for you to check; urgency about a case with no deadline is the tell.
Common Questions
Is there a NEC settlement I can claim from?
No. Abbott agreed in August 2026 to pay approximately $670 million to resolve about 2,000 claims, but those claimants were already represented by three specific plaintiffs' firms. No claims administrator was appointed, no claim form was published and no deadline was set, because it is not a class settlement. Mead Johnson and Reckitt have no settlement at all. Entering this litigation means bringing a lawsuit, not filing a claim.
What is a bellwether trial and why does it matter?
When hundreds of similar cases are consolidated, courts try a small number of representative ones first. Those bellwether verdicts do not bind the other cases, but they show both sides how juries respond to the same scientific evidence, the same internal documents and the same witnesses. That information is what usually drives settlement discussions. Inman v. Mead Johnson is the first of four initial bellwethers from MDL 3026 to reach a jury.
Didn't a jury already award $60 million against Mead Johnson?
In March 2024, yes — and that verdict was overturned on appeal on 16 June 2026, on grounds including errors in the jury instructions and in evidence that was admitted. It is still quoted widely as though it stands. It does not. The verdict that did survive review is the $495 million award against Abbott, upheld by a Missouri appellate court on 8 May 2026.
My baby had NEC. Does that mean I have a case?
Not on its own. NEC occurs in premature infants who were never given cow's-milk-based formula, and prematurity itself is a risk factor. What these cases turn on is documentation: that the infant was born prematurely, that a cow's-milk-based preterm formula or fortifier was actually given, and that NEC was diagnosed. NICU feeding records are usually decisive, and whether a claim is still timely depends on the law of the state involved.
How long do I have to bring a claim?
It depends on the state, and there is no single answer. Time limits for injury claims vary from state to state, and claims involving an injury to a child or a death commonly run on different clocks from ordinary injury claims. Some of these clocks are measured from the injury, some from the date it was or should have been discovered. Because these injuries date back years in many cases, the timing question is often the first thing a lawyer examines.
Which products are involved?
The litigation concerns cow's-milk-based products formulated for premature infants: Abbott's Similac preterm range and Mead Johnson's Enfamil Premature, along with associated human-milk fortifiers made from cow's milk. Standard term-infant formula sold for healthy full-term babies is not what these cases are about, and NICU feeding with pasteurised donor human milk falls outside the litigation entirely.
What happens after this trial ends?
Whichever way it goes, three further initial bellwether cases remain scheduled, and a single verdict rarely resolves an MDL of this size. A plaintiff verdict tends to strengthen settlement pressure on Mead Johnson, which so far has settled nothing; a defence verdict tends to reduce it. Either outcome can also be appealed, as has already happened twice in this litigation with opposite results.
Does Abbott's $670 million settlement mean the litigation is ending?
It resolves a portion of Abbott's exposure — roughly 2,000 claims out of a litigation that also includes hundreds of federal cases and continuing state filings — and it does not touch Mead Johnson at all. Abbott described it as a step toward substantially resolving the litigation rather than as a global resolution. The federal trial now underway is against Mead Johnson precisely because that side of the case remains unresolved.
Separate from this case: were you injured in the last 2 years?
Class-action payouts are fixed amounts through an administrator. A personal injury claim is a different case — and often worth far more. Free estimate, no obligation.